Haemonetics Corp (HAE)
94.80
-1.69
(-1.75%)
USD |
NYSE |
May 16, 16:00
94.83
+0.03
(+0.03%)
After-Hours: 20:00
Haemonetics Gross Profit (TTM): 691.55M for March 31, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 691.55M |
December 31, 2023 | 671.89M |
September 30, 2023 | 652.73M |
June 30, 2023 | 640.10M |
March 31, 2023 | 615.10M |
December 31, 2022 | 595.16M |
September 30, 2022 | 575.02M |
June 30, 2022 | 539.68M |
March 31, 2022 | 505.50M |
December 31, 2021 | 451.00M |
September 30, 2021 | 432.69M |
June 30, 2021 | 415.89M |
March 31, 2021 | 397.84M |
December 31, 2020 | 429.59M |
September 30, 2020 | 437.38M |
June 30, 2020 | 458.64M |
March 31, 2020 | 484.51M |
December 31, 2019 | 482.17M |
September 30, 2019 | 465.29M |
June 30, 2019 | 450.20M |
March 31, 2019 | 417.54M |
December 31, 2018 | 410.71M |
September 30, 2018 | 410.83M |
June 30, 2018 | 403.49M |
March 31, 2018 | 411.91M |
Date | Value |
---|---|
December 31, 2017 | 389.63M |
September 30, 2017 | 379.42M |
June 30, 2017 | 379.10M |
March 31, 2017 | 378.49M |
December 31, 2016 | 385.61M |
September 30, 2016 | 393.38M |
June 30, 2016 | 394.43M |
March 31, 2016 | 405.91M |
December 31, 2015 | 425.06M |
September 30, 2015 | 427.86M |
June 30, 2015 | 430.68M |
March 31, 2015 | 434.42M |
December 31, 2014 | 441.49M |
September 30, 2014 | 451.46M |
June 30, 2014 | 463.23M |
March 31, 2014 | 468.37M |
December 31, 2013 | 476.07M |
September 30, 2013 | 467.55M |
June 30, 2013 | 449.43M |
March 31, 2013 | 428.13M |
December 31, 2012 | 399.60M |
September 30, 2012 | 382.42M |
June 30, 2012 | 370.60M |
March 31, 2012 | 369.24M |
December 31, 2011 | 362.13M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
397.84M
Minimum
Mar 2021
691.55M
Maximum
Mar 2024
519.60M
Average
483.34M
Median
Gross Profit (TTM) Benchmarks
Stryker Corp | 13.38B |
ResMed Inc | 2.557B |
Masimo Corp | 960.40M |
Insulet Corp | 1.226B |
InfuSystems Holdings Inc | 64.04M |